MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinsonism"

  • 2016 International Congress

    Modulation and mechanism for the neuroprotective effects of 17-beta-estradiol: Relevance to depressive symptoms in Parkinson’s disease

    P. Kumar, N. Baquer (New Delhi, India)

    Objective: The objective of this study was to investigate neuroprotective potential of 17β estradiol (E2) treatment on the activities of acetylcholinesterase and monoamine oxidase, membrane…
  • 2016 International Congress

    Translation of the European physiotherapy guideline for Parkinson’s disease to Portuguese

    T.T.C. Capato, L.R.S. Almeida, J.M.M. Domingos, B. Bolem, S. Keus (São Paulo, Brazil)

    Objective: To translate and adapt the European Physiotherapy Guideline for Parkinson's disease to Portuguese. Background: In 2014 the European Guideline for Physiotherapy in Parkinson's disease…
  • 2016 International Congress

    Parkinsonian syndrome prevalence in the world

    F. Gulyamova (Tashkent, Uzbekistan)

    Objective: To analyze the static data in the incidence of Parkinson's disease in the world. Background: Parkinson's disease is considered a progressive multisystem disorder involving…
  • 2016 International Congress

    Gender effect on non-motor symptoms in Parkinson’s disease: Are men more at risk for most of them?

    R. Vasta, A. Nicoletti, G. Mostile, G. Nicoletti, G. Arabia, G. Iliceto, P. Lamberti, R. Marconi, L. Morgante, P. Barone, A. Quattrone, M. Zappia (Catania, Italy)

    Objective: To evaluate the burden of non-motor symptoms (NMS) among patients affected by Parkinson's disease (PD) with respect to the general population and to evaluate…
  • 2016 International Congress

    A comparison study of health-related quality of life between female and male patients with Parkinson’s disease

    B. Donmez Colakoglu, T. Kahraman, E. Goz, F. Soke, A. Genc, P. Keskinoglu (Izmir, Turkey)

    Objective: To investigate the effect of gender difference on health-related quality of life in patients with Parkinson's disease (PD). Background: PD has a negative impact…
  • 2016 International Congress

    Effect of European physiotherapy guideline for Parkinson´s disease and Microsoft Kinect® adventures games training on postural control, cognition and quality of life: Randomized clinical trial

    J.E. Pompeu, K.G. Silva, T.B. Freitas, R.A. Nuvolini, F. Doná, C. Torriani-Pasin, F.F. Ganaça, H.B. Ferraz (Sao Paulo, Brazil)

    Objective: To compare the effects obtained through the European Physiotherapy Guideline (EPG) for Parkinson´s disease (PD) with the Kinect Adventures games training on postural control,…
  • 2016 International Congress

    Roles of combined functional catechol-o-methyltransferase genotypes in Chinese Parkinson’s disease: A cross-sectional survey

    Y. Qian, X. Yang, S. Xu, J. Liu, Q. Xiao (Shanghai, People's Republic of China)

    Objective: To investigate the association of the most common functional catechol-O-methyltransferase (COMT) gene haplotypes with risk to develop of Parkinson's disease (PD) and the association…
  • 2016 International Congress

    Investigating voice as a biomarker of LRRK2-associated Parkinson’s disease (PD)

    S. Arora, N.P. Visanji, T.A. Mestre, T. Ghate, A.E. Lang, M. Little, C. Marras (Birmingham, United Kingdom)

    Objective: To test for an association between LRRK2 mutation and pathological changes in voice. Background: Voice impairment, characterized by reduced volume, breathiness, roughness and exaggerated…
  • 2016 International Congress

    Novel PLA2G6 c.1627C>T homozygous mutation and response to DBS-GPi

    A.D. Magalhães, L. Correia Guedes, M. Coelho, T. Teodoro, A. Valadas, H. Carvalho, B. Cattoni, J.J. Ferreira (Lisbon, Portugal)

    Objective: We present a novel homozygous PLA2G6 mutation and response to Deep Brain Stimulation (DBS). Background: Neurodegeneration with brain iron accumulation (NBIA) type 2/PLA2G6 is…
  • 2016 International Congress

    Objective methods for quantifying the deep brain stimulation (DBS) efficacy in subthalamic-nuclei (STN) neurons with microelectrode recording (MER) technology

    V.R. Rama Raju, R.K. Mridula, R. Borgohain, V. Rama Raju (Hyderabad, India)

    Objective: To design a computational modeling to develop a new diagnostic tool for effective neuro-medical-diagnostics for end users, to investigate and evaluate the potential benefits…
  • « Previous Page
  • 1
  • …
  • 359
  • 360
  • 361
  • 362
  • 363
  • …
  • 405
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • #24475 (not found)
  • Preclinical characterization of UCB0022, an oral, brain penetrant, selective, clinical-stage positive allosteric modulator of the dopamine 1 receptor (D1 PAM)
  • Effect of marijuana on Essential Tremor: A case report
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley